Sun 0597 is a topical glucocorticoid that we have been working on, for allergic rhinitis, asthma and other applications. We are currently developing the molecule for administration as a nasal spray, an inhalation product, an ophthalmic product as well as a dermal product.
Non-systemic glucocorticoids are used to treat inflammations of the airway, skin, eye, and gastrointestinal tract. However, long term use of glucocorticoids in chronic inflammatory disorders can result in hypothalamus- pituitary- adrenal axis suppression, osteoporosis, lowered immunity, growth suppression, behavioral changes and lipid metabolism changes. Our product is likely to be free of these limiting side effects.
Sun 0597 appears to be a novel, safe non systemic glucocorticoid with a promising therapeutic index.
For updates,please see the latest investor update presentation and transcript.